GU4

2,3,4,6-tetra-O-sulfonato-alpha-D-glucopyranose

Created:	2004-06-22
Last modified:	2020-07-17

Find Related PDB Entry
2 entries where GU4 is found as a standalone ligand27 entries where GU4 is found in a branched oligosaccharide

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	40
Chiral Atom Count	5
Bond Count	40
Aromatic Bond Count	0

2D diagram of GU4

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2,3,4,6-tetra-O-sulfonato-alpha-D-glucopyranose
Synonyms	2,3,4,6-tetra-O-sulfonato-alpha-D-glucose; 2,3,4,6-tetra-O-sulfonato-D-glucose; 2,3,4,6-tetra-O-sulfonato-glucose
Systematic Name (OpenEye OEToolkits)	[(2~{S},3~{R},4~{S},5~{R},6~{R})-2-oxidanyl-3,5-disulfooxy-6-(sulfooxymethyl)oxan-4-yl] hydrogen sulfate
Formula	C₆ H₁₂ O₁₈ S₄
Molecular Weight	500.409
Type	D-SACCHARIDE, ALPHA LINKING

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OC1OC(COS(=O)(=O)O)C(OS(=O)(=O)O)C(OS(=O)(O)=O)C1OS(=O)(=O)O
SMILES	CACTVS	3.385	O[CH]1O[CH](CO[S](O)(=O)=O)[CH](O[S](O)(=O)=O)[CH](O[S](O)(=O)=O)[CH]1O[S](O)(=O)=O
SMILES	OpenEye OEToolkits	2.0.7	C(C1C(C(C(C(O1)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O
Canonical SMILES	CACTVS	3.385	O[C@H]1O[C@H](CO[S](O)(=O)=O)[C@@H](O[S](O)(=O)=O)[C@H](O[S](O)(=O)=O)[C@H]1O[S](O)(=O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O
InChI	InChI	1.03	InChI=1S/C6H12O18S4/c7-6-5(24-28(17,18)19)4(23-27(14,15)16)3(22-26(11,12)13)2(21-6)1-20-25(8,9)10/h2-7H,1H2,(H,8,9,10)(H,11,12,13)(H,14,15,16)(H,17,18,19)/t2-,3-,4+,5-,6+/m1/s1
InChIKey	InChI	1.03	SPIXVQOXHJQNTH-DVKNGEFBSA-N

Related Resource References

Resource Name	Reference
PubChem	448679

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.